<SEC-DOCUMENT>0000899243-22-016836-index.html : 20220506
<SEC-HEADER>0000899243-22-016836.hdr.sgml : 20220506
<ACCEPTANCE-DATETIME>20220505164208
ACCESSION NUMBER:		0000899243-22-016836
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20220106
FILED AS OF DATE:		20220505
DATE AS OF CHANGE:		20220505

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			ALS Invest 1 B.V.
		CENTRAL INDEX KEY:			0001920501
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41199
		FILM NUMBER:		22897147

	BUSINESS ADDRESS:	
		STREET 1:		EERSTE WELERINGDWARSSTRAAL 54E
		STREET 2:		1017 TP
		CITY:			AMSTERDAM
		STATE:			P7
		ZIP:			1017
		BUSINESS PHONE:		310630376119

	MAIL ADDRESS:	
		STREET 1:		EERSTE WELERINGDWARSSTRAAL 54E
		STREET 2:		1017 TP
		CITY:			AMSTERDAM
		STATE:			P7
		ZIP:			1017

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Amylyx Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001658551
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				464600503
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		43 THORNDIKE STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02141
		BUSINESS PHONE:		617-683-0917

	MAIL ADDRESS:	
		STREET 1:		43 THORNDIKE STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02141
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>doc3.xml
<DESCRIPTION>FORM 3 SUBMISSION
<TEXT>
Document 1 - file: doc3.html

Document 1 - RAW XML: doc3.xml

</DOCUMENT>
</SEC-DOCUMENT>